-
-
-
-
-
-
-
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
-
-
-
-
-
-
-
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Collegium Appoints Nancy S. Lurker to its Board of Directors
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Raised to $50 at H.C. Wainwright
-
-
-
-
-
-
-
Collegium Pharma (COLL) Provides 2024 Financial Guidance
-
-
-
-
-
-
-
Collegium Pharma (COLL) prices $210m upsized convertible offering
-
-
-
-
-
-
-
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
-
1,154,866 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

